MedTrace Logo

A Post-Market Clinical Investigation on Mepilex Border Post-Op

NCT04994145 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 560

Last updated 2021-12-20

No results posted yet for this study

Summary

This is a retrospective, observational (non-interventional), single-arm, single-centre, post-market clinical investigation designed to verify clinical performance and safety of Mepilex Border Post-Op when used according to clinical practice for post-operative wounds in a large and broad population.

The clinical investigation will consist of a retrospective medical record review, which will be completed with data from up to 450 female and male adult subjects who were treated with Mepilex Border Post-Op following elective hip or knee replacement at one clinic in Belgium between January 2016 and February 2021.

Conditions

  • Surgical Wound

Sponsors & Collaborators

  • Molnlycke Health Care AB

    lead INDUSTRY

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-09-01
Primary Completion
2021-12-15
Completion
2021-12-15

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04994145 on ClinicalTrials.gov